More on XENE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $36.50 |
|
|||
| Open | $36.62 | ||||
| 52 Wk High | $9.75 | ||||
| 52 Wk Low | $5.65 | ||||
| Day High | $36.62 | ||||
| Day Low | $35.41 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 195,526 | ||||
- Form 4 Xenon Pharmaceuticals For: Oct 15 Filed by: Kelly Thomas Patrick
- Guggenheim Assumes Xenon Pharmaceuticals (XENE) at Buy
- Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Xenon Pharmaceuticals (XENE) Jumps 6% Following a 35% Down Month As Insiders Report Buys
- Form 4 Xenon Pharmaceuticals For: Sep 30 Filed by: Kelly Thomas Patrick
- Form 4 Xenon Pharmaceuticals For: Sep 30 Filed by: MORTIMER IAN
- Defence Therapeutics names ex-Xenon CFO Sherry Aulin to its board
- Defence Therapeutics Appoints Finance Executive Sherry Aulin to Its Board of Directors
- Xenon Pharmaceuticals (XENE) PT Lowered to $90 at Jefferies
- Xenon to Present at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
Entities mentioned with XENE
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Jefferies & Co | View Related Stories »
- Stifel | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Show More...
